Data Foundry

Drug recalls 2026

Dopamine HCl Inj — Class II drug recall D-0853-2026

Ongoing recall by Pfizer, reported 2026-09-23, distributed nationwide. Lack of Assurance of Sterility

Recall numberD-0853-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmPfizer, Manhattan, NY, United States
Recall initiated2026-09-04
Classified2026-09-17
Reported by FDA2026-09-23
DistributedNationwide (US)
Reason classessterility
NDC00409-5820, 00409-5820-01, 00409-5820-11, 00409-9104, 00409-9104-20, 00409-9104-21
Lot numbersNL5230
Expiration dates2027-10

Product

Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.

Reason for recall

Lack of Assurance of Sterility

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0853-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-29. Not affiliated with or endorsed by FDA. Not medical or legal advice.